The Journal of clinical endocrinology and metabolism · 2017
The Influence of GH Treatment on Glucose Homeostasis in Girls With Turner Syndrome: A 7-Year Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baronio Federico, Mazzanti Laura, Girtler Ylenia, Tamburrino Federica, Lupi Fiorenzo, Longhi Silvia, Fanolla Antonio, Radetti Giorgio
Аннотация
CONTEXT: Growth hormone (GH) influences glucose homeostasis mainly by negatively affecting insulin sensitivity.
OBJECTIVE: To longitudinally study insulin sensitivity [via homeostasis model assessment of insulin sensitivity (HOMA-S)], insulin secretion [insulinogenic index (IGI)], and capacity of β cells to adapt to changes in insulin sensitivity [oral disposition index (ODI)] in girls with Turner syndrome (TS) undergoing GH treatment.
DESIGN AND SETTING: Longitudinal, retrospective, 7-year study conducted in a tertiary pediatric endocrine unit and university pediatric clinic.
PATIENTS AND METHODS: We studied 104 patients with TS (mean age ± standard deviation, 9.1 ± 3.4 years) for a median of 7.2 years.
INTERVENTION: Every year, the children underwent an oral glucose tolerance test, which was used to calculate HOMA-S, IGI, and ODI.
RESULTS: HOMA-S, IGI, and ODI did not significantly change.
CONCLUSION: The results are reassuring, showing no negative influence of GH treatment on insulin sensitivity and on β-cell secretory capacity in girls with TS.
OBJECTIVE: To longitudinally study insulin sensitivity [via homeostasis model assessment of insulin sensitivity (HOMA-S)], insulin secretion [insulinogenic index (IGI)], and capacity of β cells to adapt to changes in insulin sensitivity [oral disposition index (ODI)] in girls with Turner syndrome (TS) undergoing GH treatment.
DESIGN AND SETTING: Longitudinal, retrospective, 7-year study conducted in a tertiary pediatric endocrine unit and university pediatric clinic.
PATIENTS AND METHODS: We studied 104 patients with TS (mean age ± standard deviation, 9.1 ± 3.4 years) for a median of 7.2 years.
INTERVENTION: Every year, the children underwent an oral glucose tolerance test, which was used to calculate HOMA-S, IGI, and ODI.
RESULTS: HOMA-S, IGI, and ODI did not significantly change.
CONCLUSION: The results are reassuring, showing no negative influence of GH treatment on insulin sensitivity and on β-cell secretory capacity in girls with TS.